Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Corazza

Showing results (221-230 of 352) with videos related to

Pageof 36
Sort By:
European Journal of Internal Medicine|April 11, 2013
Dental enamel defects in adult coeliac disease: prevalence and correlation with symptoms and age at diagnosisLucia Trotta, Federico Biagi, Paola I Bianchi, et al.
Oncology Letters|August 7, 2012
Tumors of the gastroesophageal junction have intermediate prognosis compared to tumors of the esophagus and stomach, but share the same clinical determinantsPaolo G Gobbi, Manuela Bergonzi, Donatella Pozzoli, et al.
Gut|September 15, 2000
Immune reaction against the cytoskeleton in coeliac diseaseM G Clemente, M P Musu, F Frau, et al.
Neurology|June 10, 2009
Cerebellar signs in celiac diseaseM Versino, D Franciotta, S Colnaghi, et al.
Human Immunology|December 1, 1990
Reassessment of HLA association with celiac disease in special reference to the DP associationM Colonna, W Mantovani, G R Corazza, et al.
Scandinavian Journal of Gastroenterology|September 23, 1997
The smaller size of the 'coeliac iceberg' in adultsG R Corazza, M L Andreani, F Biagi, et al.
European Journal of Gastroenterology & Hepatology|March 29, 2017
Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodiesAnnalisa Schiepatti, Federico Biagi, Giacomo Fraternale, et al.
Digestive Diseases and Sciences|June 1, 1981
Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical studyF Orlandi, U Freddara, M T Candelaresi, et al.
The Italian Journal of Gastroenterology|November 1, 1992
Non-absorbable antibiotics and small bowel bacterial overgrowthG R Corazza, M Sorge, A Strocchi, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Oral butyrate for mildly to moderately active Crohn's diseaseA Di Sabatino, R Morera, R Ciccocioppo, et al.
Pageof 36

Showing results (221-230 of 352) with videos related to

Sort By:
Pageof 36
European Journal of Internal Medicine|April 11, 2013
Dental enamel defects in adult coeliac disease: prevalence and correlation with symptoms and age at diagnosisLucia Trotta, Federico Biagi, Paola I Bianchi, et al.
Oncology Letters|August 7, 2012
Tumors of the gastroesophageal junction have intermediate prognosis compared to tumors of the esophagus and stomach, but share the same clinical determinantsPaolo G Gobbi, Manuela Bergonzi, Donatella Pozzoli, et al.
Gut|September 15, 2000
Immune reaction against the cytoskeleton in coeliac diseaseM G Clemente, M P Musu, F Frau, et al.
Neurology|June 10, 2009
Cerebellar signs in celiac diseaseM Versino, D Franciotta, S Colnaghi, et al.
Human Immunology|December 1, 1990
Reassessment of HLA association with celiac disease in special reference to the DP associationM Colonna, W Mantovani, G R Corazza, et al.
Scandinavian Journal of Gastroenterology|September 23, 1997
The smaller size of the 'coeliac iceberg' in adultsG R Corazza, M L Andreani, F Biagi, et al.
European Journal of Gastroenterology & Hepatology|March 29, 2017
Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodiesAnnalisa Schiepatti, Federico Biagi, Giacomo Fraternale, et al.
Digestive Diseases and Sciences|June 1, 1981
Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical studyF Orlandi, U Freddara, M T Candelaresi, et al.
The Italian Journal of Gastroenterology|November 1, 1992
Non-absorbable antibiotics and small bowel bacterial overgrowthG R Corazza, M Sorge, A Strocchi, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Oral butyrate for mildly to moderately active Crohn's diseaseA Di Sabatino, R Morera, R Ciccocioppo, et al.
Pageof 36